Back
Renaissance IPO ETF Vs. Kymera Therapeutics Industry Stock Comparison
Buy
86
IPO
Renaissance IPO ETF
Last Price:
40.44
Seasonality Move:
5.78%
Sell
45
KYMR
Kymera Therapeutics
Last Price:
33.60
Seasonality Move:
34.28%
Buy
86
Renaissance IPO ETF (IPO)
is a Buy
Is Renaissance IPO ETF a Buy, Sell or Hold?
- The current Renaissance IPO ETF [IPO] share price is $40.44. The Score for IPO is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
- IPO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
45
Kymera Therapeutics (KYMR)
is a Sell
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $33.52. The Score for KYMR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- KYMR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IPO Stock Price Chart
What is Renaissance IPO ETF's stock price today?
-
The Renaissance IPO ETF share price today is $40.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPO is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $33.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing slight selling pressure.
IPO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 60.04 | Buy |
| Chaikin Money Flow: | 49509 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 39.11 | Sell |
| Chaikin Money Flow: | -120938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
IPO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.85 | Buy |
| 20-day SMA: | 39.05 | Buy |
| 50-day SMA: | 39.33 | Buy |
| 200-day SMA: | 35.47 | Buy |
| 8-day EMA: | 39.81 | Buy |
| 20-day EMA: | 39.32 | Buy |
| 50-day EMA: | 38.94 | Buy |
| 200-day EMA: | 36.3 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.92 | Sell |
| 20-day SMA: | 36.2 | Sell |
| 50-day SMA: | 36.62 | Sell |
| 200-day SMA: | 27.16 | Buy |
| 8-day EMA: | 34.84 | Sell |
| 20-day EMA: | 35.61 | Sell |
| 50-day EMA: | 36.05 | Sell |
| 200-day EMA: | 31.12 | Buy |
Renaissance IPO ETF Earnings Growth & IPO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.31 per share.
Renaissance IPO ETF Technical Analysis
| May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||